Vertos Medical focuses on treating chronic lower back pain from lumbar spinal stenosis and is behind the Mild procedure, according to an Aug. 22 news release. The acquisition will strengthen Stryker’s minimally invasive pain management portfolio and treatments available for ASCs.
In June, Vertos Medical raised $26 million to expand the Mild procedure, and the company promoted two of its leaders to C-suite roles in August.
The transaction is subject to customary closing conditions, and Stryker and Vertos Medical will continue to operate as separate entities.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
